Last reviewed · How we verify
Blood sampling for pharmacokinetics — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Blood sampling for pharmacokinetics (Blood sampling for pharmacokinetics) — Erasmus Medical Center. Blood sampling for pharmacokinetics is a clinical procedure to measure drug concentrations in blood over time to assess absorption, distribution, and elimination.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Blood sampling for pharmacokinetics TARGET | Blood sampling for pharmacokinetics | Erasmus Medical Center | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Blood sampling for pharmacokinetics CI watch — RSS
- Blood sampling for pharmacokinetics CI watch — Atom
- Blood sampling for pharmacokinetics CI watch — JSON
- Blood sampling for pharmacokinetics alone — RSS
Cite this brief
Drug Landscape (2026). Blood sampling for pharmacokinetics — Competitive Intelligence Brief. https://druglandscape.com/ci/blood-sampling-for-pharmacokinetics. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab